3 Great Webinars: Safety, Toxicology, and Combination Therapies
This is a great time to learn about breakout technologies in phenotypic drug development. Here is a short list of some great webinars you don’t want to miss:
System Investigation of Biologic Effects of Rheumatoid Arthritis Treatments using Phenotypic Profiling
Speaker: Ernest Choy, MD, FRCP, Head of Rheumatology, Section of Rheumatology, Institute of Infection and Immunity, Cardiff University
In this webinar, Dr. Choy discusses the use of phenotypic profiling to investigate combination treatments for rheumatoid arthritis and how this approach leads to better insights into the potential in in vivo effects of these drugs.
A Phenotypic Platform for Characterization of Drug Safety Mechanisms in Human Primary Cell Disease Models
Speaker: Ellen Berg, PhD, General Manager BioSeek, DiscoverX
In this webinar, Dr. Berg will introduce a new tool for preclinical safety developed to identify signatures of toxicity using human primary cell models of human disease.
Human Primary Cell-Based In Vitro Systems for Translational Drug Safety and Mechanisms of Toxicity
Speaker: Ellen Berg, PhD, General Manager BioSeek, DiscoverX
In this webinar, Dr. Berg will discuss how in vitro system data and computational methods can be used to identify mechanisms of toxicity of compounds during drug development.
